Novakovic T. (ZEM Solutions, Belgrade, Serbia). Публикации

№Библиографическая ссылкаГод

Статьи в журналах/сборниках из перечня Web of Science/Scopus
1Moorkens E., Godman B., Huys I., Hoxha I., Malaj A., Keuerleber S., Stockinger S., Dimitrova M., Tachkov K., Voncina L., Palcevski V.V., Achniotou G., Slabý J., Popelková L., Kohoutová K., Bartels D., Laius O., Martikainen J.E., Selke G., Kourafalos V., Magnusson E., Einarsdóttir R., Adams R., Joppi R., Allocati E., Jakupi A., Viksna A., Greičiūtė-Kuprijanov I., Bonanno P.V., Suttorp V., Melien O., Plisko R., Mardare I., Мешков Д.О., Novakovic T., Furst J., Zara C., Markovic-Pekovic V., Befrits G., Puckett R., Vulto A.G., Mortenhuber S. The expiry of Humira® market exclusivity and the entry of Adalimumab biosimilars in Europe: An overview of pricing and national policy measurese // Frontiers in Pharmacology. 2021. т 11. С. 1-17 https://www.frontiersin.org/articles/10.3389/fphar.2020.591134/full.2021
2Brian G.Н., Bonanno P.V., Bucsics A.Н., Oortwijn W.Н., Rothe C.C., Ferrario A.Н., Bosselli S.Н., Hill A.Н., Martin A.P., Simoens S.Н., Kurdi A., Gad M., Gulbinovic J., Timoney A., Bochenek T., Salem A., Hoxha I., Sauermann R., Massele A., Guerra Jr. A. A., Petrova G., Mitkova Z., Achniotou G., Laius O., Sermet C., Selke G., Kourafalos V., Yfantopoulos J., Magnusson E., Joppi R., Oluka M., Hye-Young Kwon -., Jakupi A., Kalemeera F., Fadare J. O., Melien O., Pomorski M., Wladysiuk M., Markovic´ -Pekovic V., Mardare I., Novakovic T., Furst J., Tomek D., Zara C., Diogene E., Meyer J.C., Malmstrom R.E., Wettermark B., Matsebula Z., Campbell S., Haycox A., Мешков Д.О. Barriers for Access to New Medicines: Searching for the balance between rising costs and limited budgets // Frontiers in Public Health. 2018. December 2018, Volume 6. С. Article 328.2018
3Мешков Д.О., Godman B., Bucsics A.Н., Bonanno P.V., Oortwijn W., Rothe C.C., Ferrario A.Н., Boselli S., Hill A.Н., Martin A.P., Simoens S.Н., Gad M., Kurdi A., Gulbinovic J., Timoney A., Bochenek T., Salem A., Hoxha I., Sauermann R., Massele A., Guerra Jr. A. A., Petrova G., Achniotou G., Laius O., Sermet C., Selke G., Kourafalos V., Yfantopoulos J., Magnusson E., Joppi R., Oluka M., Kwon H.-Y., Jakupi A., Kalemeera F., Fadare J. O., Melien O., Wladysiuk M., Markovic-Pekovic V., Mardare I., Novakovic T., Furst J., Tomek D., Zara C., Diogene E., Meyer J.C., Malmstrom R.E., Wettermark B., Matsebula Z., Campbell S., Haycox A. Barriers for Access to New Medicines: Searching for the balance between rising costs and limited budgets // Frontiers in Public Health. 2018. V.6. С. 1-21.2018
4Ferrario A.Н., Bochenek T., Arāja D., Danko D., Catic T., Dimitrova M., Furst J., Greičiūtė-Kuprijanov I., Hoxha I., Jakupi A., Laidmäe E., Loblová O., Mardare I., Markovic´ -Pekovic V., Novakovic T., Petrova G., Pomorski M., Tomek D., Voncina L., Haycox A., Kanavos P., Bonanno P.V., Godman B., Мешков Д.О. The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications // PharmacoEconomics. 2017. Volume 35, Issue 12. С. 1271–1285 https://link.springer.com/article/10.1007%2Fs40273-017-0559-4.2017